Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 474 | 865 | 795 | 440 |
| Gross Profit | N/A | 474 | 865 | 795 | 440 |
| Operating Expenses | 11,755 | 10,443 | 11,913 | 10,418 | 30,024 |
| Operating Income | -11,755 | -9,969 | -11,048 | -9,623 | -29,583 |
| Interest Expense | 211 | 51 | 66 | 61 | 553 |
| Other Income | 4,326 | 709 | 615 | 1,287 | 1 |
| Pre-tax Income | -7,641 | -9,311 | -10,499 | -8,396 | -30,136 |
| Income Tax | -320 | -505 | -1,029 | -888 | -1,645 |
| Net Income Continuous | -7,321 | -8,806 | -9,470 | -7,508 | -28,491 |
| Net Income | $-7,321 | $-8,806 | $-9,470 | $-7,508 | $-28,491 |
| EPS Basic Total Ops | -127.79 | -2,487.80 | -191,720.00 | -0.48 | -3.34 |
| EPS Basic Continuous Ops | -147.82 | -2,787.90 | -191,616.90 | -0.47 | -3.33 |
| EPS Diluted Total Ops | -127.79 | -2,487.80 | -191,720.00 | -0.48 | -3.34 |
| EPS Diluted Continuous Ops | -147.82 | -2,787.90 | -191,616.90 | -0.47 | -3.33 |
| EPS Diluted Before Non-Recurring Items | -127.80 | -2,487.50 | -191,800.00 | -192,000.00 | N/A |
| EBITDA(a) | $-11,431 | $-9,617 | $-10,624 | $-9,069 | $-28,021 |